Skip to main content
Full access
Brief Reports
Published Online: 5 October 2018

Racial and Ethnic Differences in Use of State-Operated Inpatient Substance Abuse Services, 2004–2005 Versus 2010–2011

Abstract

Objective:

This study examined ethnic-racial differences in referral source, length of stay, legal status, and diagnosis in state-operated substance abuse inpatient treatment in Connecticut.

Methods:

Data from 2004–2005 (N=1,484) and from 2010–2011 (N=4,529) were investigated with regression analyses.

Results:

At both time points, African Americans were more likely than other groups to be referred by criminal justice sources, Hispanics were more likely than whites to be referred by other sources, and whites were more likely than African Americans to have emergency-crisis admissions; length of stay was shorter for Hispanics than for whites and longer for African Americans than for whites and Hispanics; and Hispanics were less likely than other groups to have an alcohol use disorder, more likely than other groups to have a drug use disorder, and more likely than whites to receive a discharge diagnosis of a personality disorder from cluster B.

Conclusions:

Targeted interventions to address racial-ethnic differences in inpatient addiction treatment are needed.
Studies investigating racial-ethnic differences in substance use treatment access, care, and discharge are necessary to ensure equal access to high-quality care as predicated by the Affordable Care Act. This study was part of the Health Disparities Initiative (HDI) of the Connecticut Department of Mental Health and Addiction Services (CT DMHAS), which investigates inequities in systems of care and addresses them through implementation of culturally competent practices.
Access to substance abuse treatment is often limited for persons from racial-ethnic minority groups. A study published in 2011 reported that Hispanics and African Americans were less likely than whites to receive inpatient substance abuse treatment (1). For Hispanics, these differences were significant after the analysis controlled for the independent or cumulative effects of need, socioeconomic status (SES), and criminal history; however, for African Americans, the differences were significant only when the analysis controlled simultaneously for need, SES, and criminal history (1). Similar results were found for use of outpatient substance abuse services (2). African Americans were more likely than whites to report no access to services, and Hispanics were more likely than whites to report delayed receipt of care or receipt of less care than needed. Furthermore, African Americans and Hispanics were less likely than whites to be in active treatment (i.e., to be currently engaged in treatment activities beyond assessment only) (2).
Diagnostic differences have also been documented for persons from racial-ethnic minority groups. Compared with whites, Hispanics and African Americans tend to report more alcohol or drug abuse (3). However, when diagnostic patterns are analyzed, African Americans are more likely than whites to be given a diagnosis of a drug use disorder only and Hispanics are more likely than whites to be given a diagnosis of an alcohol use disorder only (4). Studies that might explain these differences are limited. Experts argue that sociocultural differences between providers and patients (for example, cultural worldviews) influence their expectations of each other and their communication, which in turn, affects the treatment process (5).
Exit from substance abuse treatment is often premature among persons from racial-ethnic minority groups. Shorter stays and early termination are associated with poor clinical outcomes (69). African Americans and Hispanics are less likely than whites to complete substance abuse treatment and more likely to end treatment before attaining significant progress (10).
The purpose of this retrospective and exploratory study was to investigate racial-ethnic (African American, Hispanic, and white) differences in treatment-related factors and diagnosis in two independent samples of adults who received state-operated substance abuse inpatient services, at two time points (time 1, 2004–2005; and time 2, 2010–2011). Because substance use disorders tend to be chronic and pervasive, inpatient treatment is often vital to obtain successful outcomes; therefore, investigating these differences in inpatient settings is an essential step in monitoring health care equity and identifying specific targets of intervention.
In light of the HDI’s efforts to increase cultural competence and decrease disparities, the hypothesis was that racial-ethnic differences documented at time 1 would decrease at time 2 as evidenced by lack of statistical significance or by decreases in odds ratios (ORs) at time 2. Inferences regarding the association between the HDI’s interventions and racial-ethnic differences were not possible given the study’s design.

Methods

This study was approved by the Yale University Human Investigation Committee and the CT DMHAS Institutional Review Board. Data extracts for these analyses were provided by the Information Services and the Evaluation, Quality Management, and Improvement Divisions of CT DMHAS from its Electronic Data Warehouse. At time 1, a random-extract method (that is, a computer-generated selection in which all unduplicated persons in each ethnic and racial category had an equal chance of being selected) was used to obtain a sample that was representative of the adult population (ages ≥18) that received substance abuse services at state-operated inpatient facilities in Connecticut from 2004 to 2005 (495 African Americans, 492 Hispanics, and 497 whites). For time 2, all persons identified as being African American (N=759; race coded as “black” and ethnicity as “non-Hispanic”), Hispanic (N=781; race coded as “white” or “other” and ethnicity as “Hispanic”), and white (N=2,989; race coded as “white/Caucasian” and ethnicity as “non-Hispanic”) in fiscal year 2010–2011 were included in the analysis. Clients who received services at different types of inpatient addiction treatment centers (e.g., detox, short-term inpatient, and long-term inpatient) were included in the analyses. Persons with missing race or ethnicity information and groups with limited representation (that is, clients from a multiracial background or with multiple ethnicities or clients from other races) were excluded.
To assess the relationship between race-ethnicity and treatment-related variables, logistic and linear regressions were conducted, controlling for demographic factors and symptom severity. The controlling variables (Table 1) were entered first, followed by race-ethnicity. The same data analytic procedures were conducted for times 1 and 2. ORs <1 indicate lower odds, and ORs ≥1 indicate higher odds. ORs can also be interpreted as measures of effect size in order to quantify the magnitude of change over time. For length of stay, we conducted linear regressions, reporting standardized betas.
TABLE 1. Regression analysis of racial-ethnic differences as predictors of treatment outcomes among persons receiving state-operated inpatient substance abuse treatment during two periodsa
 African Americanvs. whiteHispanic vs. whiteAfrican Americanvs. Hispanic
Variable2004–20052010–20112004–20052010–20112004–20052010–2011
Referral source      
 Self1.03.841.44*.75*.72*1.12
 Criminal justice2.76***1.71**.8.933.44***1.84*
 Other (for example, family, outpatient, or residential)1.961.273.28**2.11***.6.60*
Legal status at admission      
 Voluntary1.351.521.56*2.41**1.16.63
 Emergency or crisis.55**.08*.58*.30.94.26
Length of stayb.08*.06***−.14***−.03*.22***.09***
Axis I diagnosis at admission      
 Alcohol use disorder.60**1.26*.21***.50***2.83***2.50***
 Drug use disorder1.56**.81*4.12***2.00***.38***.41***
Axis II diagnosis      
 At admission      
  Cluster B personality disorder1.431.76.542.60**2.64.68
  Personality disorder NOS1.591.55.412.07*3.91*.75
  No diagnosis or diagnosis deferred.75.57*2.44*.42***1.341.36
 At discharge      
  Cluster B personality disorder2.11*1.071.99*1.78*1.06.60
  No diagnosis or diagnosis deferred.661.00.63*.55***1.061.84***
a
Only findings that were significant at time 1 or time 2 are shown. Unless otherwise specified, results are presented for admission only. At discharge, models were significant and in the same direction, unless otherwise specified, except for the Hispanic versus white comparison, which was not significant for axis I alcohol use disorder at discharge. Control variables included binary variables of gender (female versus male), marital status (married or civil union versus never married, divorced, or single), education level (no high school degree versus at least a high school degree or a GED), housing status (homeless versus housed), and employment status (unemployed versus employed full- or part-time) and continuous variables of age and Global Assessment of Functioning score at admission. Findings shown are from the final regression step in which all variables were included.
b
Values are standardized beta coefficients from linear regression models. All other values are odds ratios for the predictors from logistic regression models.
*
p<.05, **p<.01, ***p<.001
The dependent variables included referral source (self-referral, inpatient services, criminal justice system, and crisis or emergency services), legal status at admission (voluntary, criminal justice system, and emergency certification), discharge reason (facility concurs or does not concur with discharge), DSM-IV-TR axis I diagnosis at admission and discharge (alcohol and drug use disorders,) and axis II diagnosis (personality disorders cluster A, B, and C, personality disorders not otherwise specified [NOS], intellectual disability or borderline IQ, and diagnosis deferred), and length of stay (number of days). Cluster B personality disorders are histrionic, narcissistic, borderline, and antisocial. Categorical variables were recoded as yes or no.

Results

Table 1 shows the results of the logistic and linear regressions at times 1 and 2 (only findings that were significant at time 1 or time 2 are shown). [Tables presenting significant results of the full models from the regression analyses and summarizing differences in demographic characteristics are included in an online supplement to this report.] At time 1, Hispanics were more likely than whites and African Americans to self-refer to services. In contrast, at time 2, Hispanics were less likely than whites to self-refer. At both time points, African Americans were more likely than whites and Hispanics to be referred by the criminal justice system, although the ORs at time 2 were smaller than at time 1, suggesting smaller effect sizes. Furthermore, at both time points, Hispanics were more likely than whites to be referred by other sources (for example, family and friends), with a smaller effect size at time 2.
With respect to legal status, at times 1 and 2, Hispanics were more likely than whites to begin treatment voluntarily, with a larger effect size at time 2. At time 1, African Americans and Hispanics were less likely than whites to be committed to treatment on an emergency basis. At time 2, only the African American–white difference remained significant, with a larger effect size than at time 1.
At times 1 and 2, length of stay for African Americans was longer than that of the other groups. In contrast, length of stay for Hispanics at both time points was shorter than for whites and African Americans.
At time 1, whites were more likely than the other groups to be diagnosed as having an alcohol use disorder. At time 2, African Americans were more likely than whites to be diagnosed as having an alcohol use disorder. At both time points, Hispanics were the group least likely to be diagnosed as having an alcohol use disorder. At time 1, Hispanics were more likely than whites or African Americans to receive diagnoses of drug use disorders, and African Americans were more likely than whites to receive these diagnoses. At time 2, Hispanics continued to be the group most likely to receive a diagnosis of a drug use disorder, and African Americans were less likely than whites to receive a diagnosis of a drug use disorder.
Hispanics were more likely than whites to receive a cluster B personality disorder diagnosis at time 2 admission and at times 1 and 2 discharge. At time 1 discharge, African Americans were more likely than whites to receive this diagnosis. In addition, African Americans were more likely than Hispanics to receive a diagnosis of personality disorder NOS at time 1 admission, and Hispanics were more likely than whites to receive that diagnosis at time 2 admission.
At time 1 admission, Hispanics were more likely than whites to receive a deferred axis II diagnosis; however, at time 2, whites were more likely than Hispanics to receive this diagnosis. At time 2 admission, African Americans were less likely than whites to receive a deferred axis II diagnosis. At time 2 discharge, Hispanics were also less likely than African Americans to receive this diagnosis.

Discussion

These analyses compared racial-ethnic differences in state-operated substance abuse inpatient treatment units in Connecticut in two time periods: 2004–2005 and 2010–2011. Differences in self-referral changed between time points. At time 2, Hispanics were less likely to self-refer than whites, which is consistent with previous findings (11). Self-referrals imply an internal motivation to seek services; however, self-referrals may also reflect external motivations (for example, encouragement from one’s social network) (12). Racial-ethnic differences in referral by the criminal justice system remained significant between time points, with African Americans being more likely than other groups to be referred by this source. This finding is consistent with extant literature (1,11,13). Furthermore, the direction of differences in referral from other sources did not change between times 1 and 2. Congruent with previous studies, Hispanics were more likely than whites to be referred by other sources.
Differences in length of stay also remained significant between time points. African Americans tended to stay longer in treatment than whites or Hispanics, which may be the result of compulsory requirements from the criminal justice system or biases regarding this racial group. Studies have suggested that mandated as opposed to voluntary treatment is associated with less attrition and better outcomes (1,13). In contrast, and in line with other studies (14), length of stay for Hispanics was shorter than for whites, which may be attributable to a scarcity of bilingual-bicultural staff.
The findings at time 1 that whites were more likely than the other groups to have a diagnosis of an alcohol use disorder and that African Americans were more likely than the other groups to have a diagnosis of a drug use disorder are in line with previous findings (3,4), but the differences found at time 2 are not supported by the literature, warranting further investigation.
Previous research suggests that Hispanics are less likely than whites to be diagnosed as having personality disorders (15), which was not supported by our findings. However, when comorbid substance use and personality disorder diagnoses were investigated, Hispanics were more likely than whites to receive diagnoses of both personality disorders and alcohol use disorders and more likely than African Americans to receive diagnoses of both personality disorders and drug use disorders. (15). Thus a combination of substance use disorders and personality disorders might explain our findings at time 2.
Even with the large sample and the availability of data from two periods, this study had several limitations. First, the data were provided by a behavioral health system in a single state, which limits the generalizability of findings. Second, the data were not longitudinal; the set of participants studied at time 1 did not match the set at time 2, limiting the ability to track participants included in both samples and examine change over time. Third, the differences found might be due to secular factors, such as demographic characteristics, changes in practice patterns, and nonstandardized diagnostic methods.
In addition, our race-ethnicity categorization might not reflect the heterogeneity of each group. Hispanics, for instance, constitute a diverse ethnic group that varies in race. Excluding individuals identified as both black and Hispanic (which we did for consistency between times 1 and 2 analyses) is contrary to current analytic strategies. Finally, our study was exploratory in nature. Future investigations might benefit from testing specific conceptual frameworks.
Despite its limitations, this study had important strengths. To our knowledge, this is one of only a few investigations examining addiction-related differences across significantly large ethnic-racial samples at independent time points. Moreover, this study examined the relationship between multiple treatment-related variables and diagnosis and race-ethnicity.

Conclusions

This study showed that many of the racial-ethnic differences documented in 2004–2005 remained in 2010–2011, with the exception of self-referral. The findings highlight the importance of identifying systemic issues and continuing to evaluate culturally competent practices aimed at addressing inequities as well as investigating the association between treatment-related variables, diagnosis, and treatment outcomes. Closer examination of the specific findings may help determine targets for intervention. For instance, the diagnostic differences found in this study are in contrast with data about the base rates of these disorders in the community. Are the differences the result of diagnostic bias or diagnostic practices that need to be addressed? Similarly, understanding racial-ethnic differences in treatment attrition and completion is important, and reasons for these differences, such as referrals from the justice system for African Americans, should be investigated.

Supplementary Material

File (appi.ps.201600003.ds001.pdf)

References

1.
Cook BL, Alegría M: Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatric Services 62:1273–1281, 2011
2.
Wells K, Klap R, Koike A, et al: Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. American Journal of Psychiatry 158:2027–2032, 2001
3.
Results From the 2013 National Survey on Drug Use and Health: National Findings. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2014. http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
4.
McCaul ME, Svikis DS, Moore RD: Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug and Alcohol Dependence 62:9–17, 2001
5.
Williams DR, Rucker TD: Understanding and addressing racial disparities in health care. Health Care Financing Review 21:75–90, 2000
6.
Simpson DD, Joe GW, Rowan-Szal GA, et al: Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 14:565–572, 1997
7.
McKay JR: Is there a case for extended interventions for alcohol and drug use disorders? Addiction 100:1594–1610, 2005
8.
Moos RH, Moos BS: Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction 98:325–337, 2003
9.
McKay JR, Donovan DM, McLellan T, et al: Evaluation of full vs partial continuum of care in the treatment of publicly funded substance abusers in Washington State. American Journal of Drug and Alcohol Abuse 28:307–338, 2002
10.
Arndt S, Acion L, White K: How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug and Alcohol Dependence 132:547–554, 2013
11.
Chow JC, Jaffee K, Snowden L: Racial/ethnic disparities in the use of mental health services in poverty areas. American Journal of Public Health 93:792–797, 2003
12.
Urbanoski KA: Coerced addiction treatment: client perspectives and the implications of their neglect. Harm Reduction Journal 7:13, 2010
13.
Cho Y, Johnson T, Fendrich M, et al: Referral sources and substance abuse treatment outcomes at discharge. Presented at the annual meeting of the American Public Health Association, Boston, Nov 2–6, 2013
14.
Agosti V, Nunes E, Ocepeck-Welikson K: Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse 22:29–39, 1996
15.
Huang B, Grant BF, Dawson DA, et al: Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, alcohol and drug use disorders and axis I and II disorders: United States, 2001 to 2002. Comprehensive Psychiatry 47:252–257, 2006

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Untitled, by Willem de Kooning, 1944. Oil and charcoal on paper laid on board. © Art Resource, New York City.

Psychiatric Services
Pages: 1191 - 1194
PubMed: 30286708

History

Received: 6 January 2016
Revision received: 2 January 2017
Accepted: 10 February 2017
Published online: 5 October 2018
Published in print: November 01, 2018

Keywords

  1. Program evaluation, Ethnic groups, Alcohol &amp
  2. drug abuse, Public-sector psychiatry, Inpatient treatment, African American, Hispanic/Latino

Authors

Details

Maria-Cristina Cruza-Guet, Ph.D.
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.
Elizabeth H. Flanagan, Ph.D.
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.
Sue Tharnish, B.S.
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.
Ellen Boynton, B.A.
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.
Larry Davidson, Ph.D.
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.
Miriam E. Delphin-Rittmon, Ph.D. [email protected]
Dr. Cruza-Guet is with the University of Pennsylvania Graduate School of Education, Philadelphia. Dr. Flanagan and Dr. Davidson are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Ms. Tharnish, Ms. Boynton, and Dr. Delphin-Rittmon are with the Officer of the Commissioner, Connecticut Department of Mental Health and Addiction Services (CT DMHAS), Hartford. Ms. Boynton is also with the Office of Multicultural Health Equity, CT DMHAS.

Notes

Send correspondence to Dr. Delphin-Rittmon (e-mail: [email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

State of Connecticut Department of Mental Health and Addiction Services10.13039/100004823:
This research was funded by the Office of Multicultural Health Equity, CT DMHAS.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share